Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Sales | 2,243 | 1,334 | 0 | 0 | 0 |
| Gross Profit | 2,243 | 1,334 | N/A | N/A | N/A |
| Operating Expenses | 35,174 | 17,812 | 19,476 | 12,678 | 0 |
| Operating Income | -32,931 | -16,478 | -19,476 | -12,678 | N/A |
| Interest Expense | 376 | 1,400 | 168 | 151 | 0 |
| Other Income | -849 | -147 | -13 | 3 | 0 |
| Pre-tax Income | -34,156 | -18,025 | -19,657 | -12,826 | 0 |
| Net Income Continuous | -34,156 | -18,025 | -19,657 | -12,826 | N/A |
| Net Income | $-34,156 | $-18,025 | $-19,657 | $-12,826 | $N/A |
| EPS Basic Total Ops | -47.40 | -323.60 | -458.60 | -356.00 | N/A |
| EPS Basic Continuous Ops | -46.65 | -266.64 | -395.91 | -319.85 | N/A |
| EPS Diluted Total Ops | -47.40 | -323.60 | -458.60 | -356.00 | N/A |
| EPS Diluted Continuous Ops | -46.65 | -266.64 | -395.91 | -319.85 | N/A |
| EBITDA(a) | $-32,521 | $-16,040 | $-19,028 | $-12,314 | $N/A |